Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?

Free article

Comment

Mohamad Lazkani et al. JACC Cardiovasc Interv. 2016.

Free article

. 2016 Dec 12;9(23):2460-2461.

doi: 10.1016/j.jcin.2016.09.042.

No abstract available

Comment in

Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial?
Guerrero M, Feldman T, O'Neill W. Guerrero M, et al. JACC Cardiovasc Interv. 2016 Dec 12;9(23):2461. doi: 10.1016/j.jcin.2016.10.010. JACC Cardiovasc Interv. 2016. PMID: 27931601 No abstract available.

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry.
Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O'Hair D, Dumonteil N, Rodés-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa AA, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O'Neill W. Guerrero M, et al. JACC Cardiovasc Interv. 2016 Jul 11;9(13):1361-71. doi: 10.1016/j.jcin.2016.04.022. JACC Cardiovasc Interv. 2016. PMID: 27388824